Cart summary

You have no items in your shopping cart.

DCPIB

SKU: orb1219386

Description

DCPIB, a known specific and potent inhibitor of volume-regulated anion channels (VRAC),DCPIB displayed superior selectivity toward TRESK with an IC50 of 0.14 μM, demonstrating at least 100-fold higher affinity over TREK1/TRAAK channels. DCPIB, a known specific and potent inhibitor of volume-regulated anion channels (VRAC), has been reported to activate TREK1 and TREK2 in astrocytes and in vitro recently. In the present study, we demonstrated DCPIB also voltage dependently activated TRAAK besides TREK1/TREK2, showing DCPIB activated all TREK subfamily members. In contrast, the compound potently inhibited several other K2P channels with no voltage dependence, including TRESK, TASK1, and TASK3. DCPIB displayed superior selectivity toward TRESK with an IC50 of 0.14 μM, demonstrating at least 100-fold higher affinity over TREK1/TRAAK channels. Furthermore, the impaired ion selectivity filter region greatly impaired the activating effect of DCPIB on TREK1 but not the inhibitory effect of DCPIB on TRESK. This indicates distinct molecular determinants underlying the effect of DCPIB on TREK1 or TRESK channels. DCPIB played diverse effects on K2P channels and could be a useful tool for further investigating structure-function studies of K2P channels.

Images & Validation

Key Properties

CAS Number82749-70-0
MW427.36
Purity>98% (HPLC)
FormulaC22H28Cl2O4
SMILESO=C(O)CCCOC1=CC2=C(C(C(C3CCCC3)(CCCC)C2)=O)C(Cl)=C1Cl
TargetChloride Channel
SolubilityDMSO:125 mg/mL (292.49 mM)

Bioactivity

In Vivo
Animal model: Reversible middle cerebral artery occlusion (rMCAO) model. Dosage: 1 mM, 10 μL. Administration: Administered manually for 20s by intracerebroventricular infusion. Result: Diminished Pyramidal neurons injury induced by rMCAO in the CA1 region.
In Vitro
Immunofluorescence Cell line: BV2 cells. Concentration: 10 μM. Incubation time: 3 h. Result: Significantly decreased Ki67 positive staining microglia and pro-inflammatory cytokine (TNF-α, IL-1β) secretion. Western blot analysis. Cell line: BV2 cells. Concentration: 10 μM. Incubation time: 3 h. Result: Inhibited migratory potential of transient OGD (Oxygen-glucose deprivation) exposed BV2 cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • DCPIB [orb1309784]

    99.87%

    82749-70-0

    427.36

    C22H28Cl2O4

    25 mg, 1 ml x 10 mM (in DMSO), 2 mg, 5 mg, 10 mg, 50 mg, 100 mg, 200 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

DCPIB (orb1219386)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
5 mg
$ 120.00
10 mg
$ 180.00
25 mg
$ 350.00
50 mg
$ 660.00
100 mg
$ 840.00
200 mg
$ 1,180.00